A Trial of Radiotherapy and Durvalumab in DLBCL and FL
Condition(s):Diffuse Large B Cell Lymphoma; Follicular LymphomaLast Updated:February 7, 2024Active, not recruiting
Hide Studies Not Open or Pending
Condition(s):Diffuse Large B Cell Lymphoma; Follicular LymphomaLast Updated:February 7, 2024Active, not recruiting
Condition(s):Leukemia; LymphomaLast Updated:February 24, 2010Completed
Condition(s):CancerLast Updated:April 2, 2010Completed
Condition(s):Chronic Myeloproliferative Disorders; Infection; Leukemia; Lymphoma; Lymphoproliferative Disorder; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Neoplasms; Unspecified Adult Solid Tumor, Protocol SpecificLast Updated:February 15, 2013Withdrawn
Condition(s):Diffuse Large B-cell Lymphoma; Follicular Lymphoma; Marginal Zone Lymphoma; Small Lymphocytic Lymphoma; Mantle Cell Lymphoma; Chronic Lymphocytic Leukemia; High-grade B-cell Lymphoma; Primary Mediastinal Large B-cell LymphomaLast Updated:September 21, 2023Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.